| Literature DB >> 30469450 |
Ali Al-Hemoud1, Janvier Gasana2, Abdullah N Al-Dabbous3, Ahmad Al-Shatti4, Ahmad Al-Khayat5.
Abstract
Ambient air pollution in terms of fine and coarse particulate matter (PM2.5 and PM10) has been shown to increase adult and infant mortalities. Most studies have estimated the risk of mortalities through attributable proportions and number of excess cases with no reference to the time lost due to premature mortalities. Disability adjusted life years (DALYs) are necessary to measure the health impact of Ambient particulate matter (PM) over time. In this study, we used life-tables for three years (2014⁻2016) to estimate the years of life lost (YLL), a main component of DALYs, for adult mortalities (age 30+ years) and postneonatal infant mortalities (age 28+ days⁻1 year) associated with PM2.5 exposure and PM10 exposure, respectively. The annual average of PM2.5 and PM10 concentrations were recorded as 87.9 μg/m³ and 167.5 μg/m³, which are 8 times greater than the World Health Organization (WHO) air quality guidelines of 10 μg/m³ and 20 μg/m³, respectively. Results indicated a total of 252.18 (95% CI: 170.69⁻322.92) YLL for all ages with an increase of 27,474.61 (95% CI: 18,483.02⁻35,370.58) YLL over 10 years. The expected life remaining (ELR) calculations showed that 30- and 65-year-old persons would gain 2.34 years and 1.93 years, respectively if the current PM2.5 exposure levels were reduced to the WHO interim targets (IT-1 = 35 μg/m³). Newborns and 1-year old children may live 79.81 and 78.94 years, respectively with an increase in average life expectancy of 2.65 years if the WHO PM10 interim targets were met (IT-1 = 70 μg/m³). Sensitivity analyses for YLL were carried out for the years 2015, 2025, and 2045 and showed that the years of life would increase significantly for age groups between 30 and 85. Life expectancy, especially for the elderly (≥60 years), would increase at higher rates if PM2.5 levels were reduced further. This study can be helpful for the assessment of poor air quality represented by PM2.5 and PM10 exposures in causing premature adult mortalities and postneonatal infant mortalities in developing countries with high ambient air pollution. Information in this article adds insights to the sustainable development goals (SDG 3.9.1 and 11.6.2) related to the reduction of mortality rates attributed to ambient air levels of coarse and fine particulate matter.Entities:
Keywords: AirQ+; DALYs; PM2.5; YLD; YLL; burden of disease (BOD); postneonatal mortality
Mesh:
Substances:
Year: 2018 PMID: 30469450 PMCID: PMC6265960 DOI: 10.3390/ijerph15112609
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Map showing the location of the three PM2.5 monitoring stations in Kuwait (marked in red dots).
International use of the AirQ+/AirQ2.2 model.
| Country * | PM2.5 | PM10 | AP | YLL | Reference |
|---|---|---|---|---|---|
| Egypt | √ | √ | Wheida et al., 2018 | ||
| Estonia | √ | √ | √ | √ | Orru et al., 2009 ** |
| 23 European Cities | √ | √ | √ | Boldo et al., 2006 | |
| Greece | √ | √ | Moustris et al., 2017 | ||
| Iran | √ | √ | √ | √ | Faridi et al., 2018 **; Ghozikali et al., 2016; Goudarzi et al., 2017; Hadei et al., 2018; Hopke et al., 2018; Khaniabadi et al., 2018; Miri et al., 2017 |
| Italy | √ | √ | √ | √ | Fattore et al., 2011 **; Tominz et al., 2005 |
| Poland | √ | √ | Skotak and Swiatczak, 2008 | ||
| Saudi Arabia | √ | √ | Habeebullah, 2013 | ||
| South Korea | √ | √ | Jeong, 2013 |
* In alphabetical order; ** Study estimated both the AP and YLL. AP: Attributable Proportion: The fraction of the health outcome (i.e., postneonatal infant mortality) attributed to the PM10 exposure. YLL: Years of Life Lost.
Health endpoints used in the AirQ+ model in this study.
| Health Endpoint | Exposure | Cut-off Value (μg/m3) | Annual Mean (μg/m3) | RR * | β Coefficient * |
|---|---|---|---|---|---|
| Premature adult mortality, all causes | PM2.5 | 35 | 87.9 | 1.062 (1.04,1.083) | 0.2454 (0.1600, 0.3252) |
| Postneonatal infant mortality, all causes | PM10 | 70 | 167.5 | 1.04 (1.02, 1.07) | 0.2976 (0.1502, 0.5134) |
* Values in parentheses are lower and upper bounds (95% CI); RR: Relative Risk.
Adult and postneonatal mortalities for three years (2014–2016).
| Mortality | 2014 | 2015 | 2016 |
|---|---|---|---|
| Adult | 2561 | 2735 | 2685 |
| Postneonatal | 73 | 76 | 86 |
Pearson Chi-Square (χ2) = 0.913, df = 2, Sig = 0.633.
Years of Life Lost (YLL) due to premature mortality.
| Measure | Age | Central | Lower | Upper |
|---|---|---|---|---|
| YLL–2015 | all ages | 252.18 | 170.69 | 322.92 |
| YLL–2015 | age 0–64 | 89.53 | 60.60 | 114.64 |
| YLL over 10 Years–2025 | all ages | 27,474.61 | 18,483.02 | 35,370.58 |
| YLL over 10 Years–2025 | age 0–64 | 8487.28 | 5741.46 | 10,873.33 |
Values are written as 95% confidence interval: central (lower–upper).
Expected Life Remaining (ELR) and other parameters for different age groups.
| Age | ELR (years) | Delta ELR * | Entry Population | Years of Life | Hazard Rate | Survival Probability |
|---|---|---|---|---|---|---|
| 0 | 79.81 | 2.65 (1.35, 4.51) | 33,269 | 33,242 | 0.16% | 99.84% |
| 1 | 78.94 | 2.66 (1.35, 4.52) | 33,215 | 33,189 | 0.16% | 99.84% |
| 30 | 51.12 | 2.34 (1.53, 3.08) | 18,576 | 18,571 | 0.06% | 99.94% |
| 35 | 46.29 | 2.31 (1.51, 3.05) | 15,735 | 15,730 | 0.07% | 99.93% |
| 40 | 41.47 | 2.28 (1.49, 3.01) | 13,885 | 13,878 | 0.11% | 99.89% |
| 45 | 36.73 | 2.24 (1.47, 2.96) | 12,123 | 12,113 | 0.16% | 99.84% |
| 50 | 32.08 | 2.19 (1.43, 2.89) | 9910 | 9898 | 0.25% | 99.75% |
| 55 | 27.54 | 2.12 (1.39, 2.81) | 7564 | 7550 | 0.38% | 99.62% |
| 60 | 23.14 | 2.04 (1.33, 2.70) | 5561 | 5542 | 0.66% | 99.34% |
| 65 | 19.02 | 1.93 (1.26, 2.56) | 3895 | 3871 | 1.23% | 98.77% |
| 70 | 15.36 | 1.78 (1.16, 2.36) | 2812 | 2782 | 2.16% | 97.84% |
| 75 | 12.25 | 1.58 (1.03, 2.10) | 1939 | 1907 | 3.29% | 96.71% |
| 80 | 9.54 | 1.37 (0.89, 1.81) | 1042 | 1014 | 5.28% | 94.72% |
| 85 | 7.46 | 1.10 (0.72, 1.45) | 381 | 364 | 8.47% | 91.53% |
* Obtained using the lower and upper estimates of the RR values.
Figure 2AirQ+ life table evaluation for the year 2015 at the measured PM2.5 level (87.9 μg/m3).
Figure 3AirQ+ life table evaluation for the year 2045 (30-year forecast) if PM2.5 is reduced to the cut-off level (35 μg/m3).
Postneonatal infant mortality with the associated parameters.
| Central | Lower | Upper | |
|---|---|---|---|
| AP * | 22.68% | 12.18% | 35.84% |
| Excess Cases ** | 17 | 9 | 27 |
| Cases per 100,000 *** | 53.77 | 28.87 | 84.95 |
* Attributable Proportion. ** Excess number of cases attributed to PM10 exposure. *** Excess incidence (cases per 100,000 at risk).
Sensitivity analysis for YLL and premature mortality for different age groups.
| Age | Years of Life at the Current PM2.5 | Years of Life at the Cut-Off PM2.5 | ||||||
|---|---|---|---|---|---|---|---|---|
| 2015 | 2025 | 2035 | 2045 | 2015 | 2025 | 2035 | 2045 | |
| 0–1 | 66,431 | 66,431 | 66,431 | 66,431 | 66,431 | 66,431 | 66,431 | 66,431 |
| 2–9 | 261,498 | 264,168 | 264,168 | 264,168 | 261,498 | 264,168 | 264,168 | 264,168 |
| 10–19 | 274,269 | 326,535 | 329,197 | 329,197 | 274,269 | 326,535 | 329,197 | 329,197 |
| 20–29 | 226,802 | 271,655 | 324,606 | 327,251 | 226,802 | 271,655 | 324,606 | 327,251 |
| 30–39 | 171,239 | 225,351 | 270,909 | 322,526 | 171,251 | 225,508 | 271,099 | 322,757 |
| 40–49 | 129,500 | 169,332 | 222,815 | 267,848 | 129,521 | 169,714 | 223,473 | 268,644 |
| 50–59 | 86,543 | 126,119 | 164,919 | 216,988 | 86,576 | 126,807 | 166,172 | 218,779 |
| 60–69 | 45,971 | 80,746 | 117,527 | 153,736 | 46,022 | 81,899 | 119,836 | 157,075 |
| 70–79 | 21,891 | 37,249 | 65,321 | 94,749 | 21,962 | 38,888 | 69,098 | 100,819 |
| ≥80 | 7251 | 14,884 | 26,376 | 45,951 | 7314 | 16,929 | 31,683 | 56,197 |
Pearson Chi-Square (χ2) (for ages ≥ 30) = 71.327, df = 3, Sig = 0.000. Pearson Chi-Square (χ2) (for ages ≥ 60) = 132.10, df = 3, Sig = 0.000.
Figure 4Sensitivity analysis for % of life expectancy for the years 2015, 2025, 2035, 2045.